Philip Jonas Sassene
Scientific director Novo Nordisk
Philip Jonas Sassene has a strong track record in drug delivery. He has 15+ years of experience in enabling formulations with particular emphasis on enabling formulation strategies for oral delivery of peptides & proteins. He is currently employed as a Scientific Director within oral delivery technologies at Novo Nordisk A/S.
Seminars
Wednesday 29th April 2026
Fireside Peptide Delivery Discussion – Pushing the Limits of Peptide Formulation & Delivery from Novel Design to Effective Targeting Strategies for Better Patient Outcomes
3:30 pm
- How to effectively design patient-centric peptide delivery formulations (oral vs injectable)?
- How to ensure novel peptide formulations can be scalable and cost efficient during the manufacturing process?
- Where will delivery innovations take the peptide field in the next 5 years?
